Repository
How to publish
Resources
FAQs

Show simple item record

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

dc.contributor.authorMuñoz Martínez, S.
dc.contributor.authorSapena, V.
dc.contributor.authorForner, A.
dc.contributor.authorVarela Calvo, María 
dc.date.accessioned2021-11-09T07:32:55Z
dc.date.available2021-11-09T07:32:55Z
dc.date.issued2021
dc.identifier.citationJHEP Reports, 3(3), (2021); doi:10.1016/j.jhepr.2021.100260
dc.identifier.issn2589-5559
dc.identifier.urihttp://hdl.handle.net/10651/60868
dc.description.statementofresponsibilityMuñoz-Martínez, S., Sapena, V., Forner, A., Nault, J.-C., Sapisochin, G., Rimassa, L., Sangro, B., Bruix, J., Sanduzzi-Zamparelli, M., Hołówko, W., El Kassas, M., Mocan, T., Bouattour, M., Merle, P., Hoogwater, F.J.H., Alqahtani, S.A., Reeves, H.L., Pinato, D.J., Giorgakis, E., Meyer, T., Villadsen, G.E., Wege, H., Salati, M., Mínguez, B., Di Costanzo, G.G., Roderburg, C., Tacke, F., Varela, M., Galle, P.R., Alvares-da-Silva, M.R., Trojan, J., Bridgewater, J., Cabibbo, G., Toso, C., Lachenmayer, A., Casadei-Gardini, A., Toyoda, H., Lüdde, T., Villani, R., Matilla Peña, A.M., Guedes Leal, C.R., Ronzoni, M., Delgado, M., Perelló, C., Pascual, S., Lledó, J.L., Argemi, J., Basu, B., da Fonseca, L., Acevedo, J., Siebenhüner, A.R., Braconi, C., Meyers, B.M., Granito, A., Sala, M., Rodríguez-Lope, C., Blaise, L., Romero-Gómez, M., Piñero, F., Gomez, D., Mello, V., Pinheiro Alves, R.C., França, A., Branco, F., Brandi, G., Pereira, G., Coll, S., Guarino, M., Benítez, C., Anders, M.M., Bandi, J.C., Vergara, M., Calvo, M., Peck-Radosavljevic, M., García-Juárez, I., Cardinale, V., Lozano, M., Gambato, M., Okolicsanyi, S., Morales-Arraez, D., Elvevi, A., Muñoz, A.E., Lué, A., Iavarone, M., Reig, M.
dc.language.isoeng
dc.relation.ispartofJHEP Reports
dc.rights© 2021 Los autores. Publicado por Elsevier B.V. en nombre de la European Association for the Study of the Liver (EASL)
dc.rightsCC Reconocimiento - No Comercial - Sin Obra Derivada 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85105461585&doi=10.1016%2fj.jhepr.2021.100260&partnerID=40&md5=dd1dc60e2fdd64c3bb35ed3001c10c0b
dc.titleAssessing the impact of COVID-19 on liver cancer management (CERO-19)
dc.typejournal article
dc.identifier.doi10.1016/j.jhepr.2021.100260
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.jhepr.2021.100260
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Files in this item

untranslated
Name:
1-s2.0-S2589555921000367-main.pdf
Size:
487.4Kb
Format:
PDF
Description:
Versión de la editorial

This item appears in the following Collection(s)

Show simple item record

© 2021 Los autores. Publicado por Elsevier B.V. en nombre de la European Association for the Study of the Liver (EASL)
This item is protected with a Creative Commons License